Tower Research Capital (TRC)’s TCV Acquisition Corp. Class A Ordinary Shares TCVA Stock Holding History

Tower Research Capital (TRC)’s Portfolio TCVA Stock Details TCVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-34	Closed	–	–	6614
2023 Q1	$0	Buy	34 +1	+3%	+$10	﹤0.01%	6616
2022 Q4	$0	Sell	33 -1,141	-97%	-$11.3K	﹤0.01%	6694
2022 Q3	$12K	Sell	1,174 -258	-18%	-$2.53K	﹤0.01%	4407
2022 Q2	$14K	Buy	1,432 +747	+109%	+$7.29K	﹤0.01%	4184
2022 Q1	$7K	Buy	+685	New	+$6.66K	﹤0.01%	4812
2021 Q4	–	Sell	-300	Closed	-$3K	–	6821
2021 Q3	$3K	Buy	+300	New	+$2.96K	﹤0.01%	5184

Tower Research Capital (TRC)'s TCVA Position: Q2 2023 in Review

Tower Research Capital (TRC) sold out of TCV Acquisition Corp. Class A Ordinary Shares (TCVA) in Q2 2023, closing a stake of 34 shares.

Tower Research Capital (TRC) first reported a position in TCVA in Q3 2021 and held it in 6 quarters. The position peaked at $14K in Q2 2022. 0 funds tracked by Wall St. Rank hold TCVA as of Q2 2023.

Tower Research Capital (TRC) reported no remaining TCV Acquisition Corp. Class A Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 34 TCV Acquisition Corp. Class A Ordinary Shares shares in Q2 2023.
Tower Research Capital (TRC) first reported a position in TCV Acquisition Corp. Class A Ordinary Shares in Q3 2021 and held it in 6 quarters.
Tower Research Capital (TRC)'s TCV Acquisition Corp. Class A Ordinary Shares position peaked at $14K in Q2 2022.
0 funds tracked by Wall St. Rank held TCV Acquisition Corp. Class A Ordinary Shares as of Q2 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.